Table 3.
Cases occurring new-onset herpes zoster | |||
---|---|---|---|
Subgroups | Total knee replacement cohort (No. of event/ Total knee replacement patient amount in each subgroup) |
Control cohort (No. of event/ non-total knee replacement patient amount in each subgroup) |
HR (95% CI)a,b |
50-64 years old | |||
Male | 19/2517 | 23/2517 | 0.829 (0.452,1.522) |
Female | 59/3590 | 38/3590 | 1.543 (1.026,2.320) |
≥ 65 years old | |||
Male | 165/14699 | 144/14699 | 1.111 (0.889,1.389) |
Female | 419/23559 | 352/23559 | 1.162 (1.008,1.339) |
a Propensity score matching was performed on age at index, sex, race, body mass index, lab data, status of comorbidities, lifestyle, socioeconomic issues, medical utilization status, vaccination for herpes zoster status.
b Follow-up time in all analyses in this table was set as 5-years, starting from 90 days after index date